4.7 Article

Intended and Unintended Targeting of Polymeric Nanocarriers: The Case of Modified Poly(glycerol adipate) Nanoparticles

Journal

MACROMOLECULAR BIOSCIENCE
Volume 18, Issue 1, Pages -

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/mabi.201700240

Keywords

adrenals; biodegradable polymers; bones; nanoparticles; ovaries

Funding

  1. Deutsche Forschungsgemeinschaft DFG [MA 1648/8-1]
  2. Czech Science Foundation [15-02986S]
  3. Ministry of Health of the Czech Republic [16-28600A]

Ask authors/readers for more resources

Biodegradable nanoparticles based on stearic acid-modified poly(glycerol adipate) (PGAS) are promising carriers for drug delivery. In order to investigate the impact of the particle interface characteristics on the biological fate, PGAS nanoparticles are covalently and noncovalently coated with N-(2-hydroxypropyl) methacrylamide (HPMA) copolymers. HPMA copolymer-modified PGAS nanoparticles have similar particle sizes, but less negative zeta-potentials. Nano-particles are double labeled with the fluorescent dyes DiR (noncovalently) and DYOMICS-676 (covalently bound to HPMA copolymer), and their biodistribution is investigated noninvasively by multispectral optical imaging. Both covalent and noncovalent coatings cause changes in the pharmacokinetics and biodistribution in healthy and tumor-bearing mice. In addition to the intended tumor accumulation, high signals of both fluorescent dyes are also observed in other organs, including liver, ovaries, adrenal glands, and bone. The unintended accumulation of nanocarriers needs further detailed and systematic investigations, especially with respect to the observed ovarian and adrenal gland accumulation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Medicinal

Glycopolymers Decorated with 3-O-Substituted Thiodigalactosides as Potent Multivalent Inhibitors of Galectin-3

David Vrbata, Marcela Filipova, Marina R. Tavares, Jakub Cerveny, Miluse Vlachova, Milada Sirova, Helena Pelantova, Lucie Petraskova, Ladislav Bumba, Rafal Konefal, Tomas Etrych, Vladimir Kren, Petr Chytil, Pavla Bojarova

Summary: Galectin-3 plays a role in cancer-related metabolic processes. Inhibiting overexpressed Galectin-3, such as with beta-galactoside-based inhibitors, holds promise for cancer treatment. A library of inhibitors was synthesized and displayed on a suitable biocompatible carrier to enhance affinity for Gal-3. One of the candidates exhibited strong inhibitory effects in cancer cells and shows potential for Gal-3-associated cancer therapy.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Review Oncology

Targeted Drug Delivery and Theranostic Strategies in Malignant Lymphomas

Tomas Etrych, Alena Braunova, David Zogala, Lukas Lambert, Nicol Renesova, Pavel Klener

Summary: Targeted drug delivery (TDD) is an innovative and effective treatment approach that aims to minimize damage to healthy tissues. Current TDD modalities include radioimmunotherapy (RIT), antibody-drug conjugates (ADC), and new formulations based on the enhanced permeability and retention effect. Diagnostic and restaging procedures in aggressive lymphomas are based on nuclear imaging, and a theranostic approach that combines diagnostic imaging with targeted treatment is an appealing strategy in personalized medicine.

CANCERS (2022)

Article Biochemistry & Molecular Biology

Simultaneous Delivery of Doxorubicin and Protease Inhibitor Derivative to Solid Tumors via Star-Shaped Polymer Nanomedicines Overcomes P-gp- and STAT3-Mediated Chemoresistance

Libor Kostka, Ladislav Sivak, Vladimir Subr, Jirina Kovarova, Milada Sirova, Blanka Rihova, Radislav Sedlacek, Tomas Etrych, Marek Kovar

Summary: The derivative of protease inhibitor ritonavir (RD) was found to be a potent P-gp inhibitor and cancerostatic drug. In this study, high-molecular-weight HPMA copolymer conjugates with a PAMAM dendrimer core bearing both doxorubicin (Dox) and RD (Star-RD + Dox) were designed to increase the circulation half-life and maximize simultaneous delivery of Dox and RD into the tumor. It was found that Star-RD + Dox exhibited higher cytostatic and proapoptotic activities compared to other treatments in vitro, and also inhibited STAT3 signaling in vivo.

BIOMACROMOLECULES (2022)

Article Biochemistry & Molecular Biology

Innovative Approach in the Cryogenic Freezing Medium for Mesenchymal Stem Cells

Nela Pilbauerova, Jan Schmidt, Tomas Soukup, Tomas Prat, Kristina Nesporova, Vladimir Velebny, Jakub Suchanek

Summary: This study investigated the use of high-molecular-hyaluronic acid (HMW-HA) as a cryoprotectant for human mesenchymal stem cells (hMSCs) to reduce DMSO concentration in the cryopreservation medium. The results showed that HMW-HA combined with lower DMSO concentrations improved total cell count, viability, and proliferation potential of hMSCs post-cryopreservation, without affecting their differentiation ability.

BIOMOLECULES (2022)

Article Biochemistry & Molecular Biology

Macro- and Nanoscale Effect of Ethanol on Bovine Serum Albumin Gelation and Naproxen Release

Niuosha Sanaeifar, Karsten Maeder, Dariush Hinderberger

Summary: We report extended ethanol-induced gelation procedures of bovine serum albumin (BSA) at 37 degrees C and investigate the release behavior of a spin-labeled naproxen derivative (SL-NPX) from these hydrogels. The alteration of initial drug loading percentage, hydrogel incubation time, BSA and alcohol concentrations affect the release rate of SL-NPX from BSA hydrogels. BSA hydrogels offer a remarkable fine-tuning capability for controlled drug delivery.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Chemistry, Multidisciplinary

Octahedral Molybdenum Cluster-Based Nanomaterials for Potential Photodynamic Therapy

Marina Rodrigues Tavares, Kaplan Kirakci, Nikolay Kotov, Michal Pechar, Kamil Lang, Robert Pola, Tomas Etrych

Summary: In this study, biocompatible and water-soluble copolymers were utilized as carriers to overcome the delivery obstacles of photosensitizers. The results showed that the conjugates prepared by covalent interactions exhibited good colloidal stability and high luminescence quantum yields, making them potential candidates for photodynamic applications.

NANOMATERIALS (2022)

Article Chemistry, Multidisciplinary

Evaluation of linear versus star-like polymer anti-cancer nanomedicines in mouse models

Libor Kostka, Lenka Kotrchova, Eva Randarova, Carolina A. Ferreira, Iva Malatova, Hye Jin Lee, Aeli P. Olson, Jonathan W. Engle, Marek Kovar, Weibo Cai, Milada Sirova, Tomas Etrych

Summary: nanomedicines are being developed as an improved therapeutic option with reduced side effects, and this study introduces tailored nanosystems for the treatment of solid tumors or hematological malignancies. The relationship between the structure of the nanosystem and its distribution in the body was evaluated through independent assessments of the polymer carrier and drug pharmacokinetics. The results showed enhanced tumor accumulation of the polymer carriers in mice with solid tumors, as well as significant accumulation of doxorubicin bound to the polymer carriers in specific tumor types.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Chemistry, Multidisciplinary

Size-switchable polymer-based nanomedicines in the advanced therapy of rheumatoid arthritis

A. Libanska, E. Randarova, S. Skoroplyas, M. Bartos, J. Lunackova, F. Lager, G. Renault, D. Scherman, T. Etrych

Summary: This study presents biocompatible and stimuli-sensitive polymer conjugates with an anti-inflammatory drug, dexamethasone, which are designed for prolonged blood circulation, enhanced inflammatory site accumulation, site-specific drug release, and subsequent elimination via urine excretion. The polymer nanomedicines demonstrated the ability to reduce joint inflammation and arthritis-induced bone damage in a mouse model of rheumatoid arthritis.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Chemistry, Multidisciplinary

Effect of Cellular and Microenvironmental Multidrug Resistance on Tumor-Targeted Drug Delivery in Triple-Negative Breast cancer

Okan Tezcan, Asmaa Said Elshafei, Karina Benderski, Elena Rama, Maike Wagner, Diana Moeckel, Robert Pola, Michal Pechar, Tomas Etrych, Saskia von Stillfried, Fabian Kiessling, Ralf Weiskirchen, Steffen Meurer, Twan Lammers

Summary: Multidrug resistance (MDR) reduces the efficacy of chemotherapy by inducing drug efflux pumps and altering the tumor microenvironment (TME) composition, limiting drug delivery. Multidrug-resistant tumors displayed a more mesenchymal phenotype, increased collagen production, enriched TME, and enhanced vascular perfusion. Drug carriers accumulated more efficiently in resistant tumors but had a limited ability to penetrate the interstitium. Microenvironmental drug resistance affected liposomal doxorubicin performance more than free doxorubicin.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Nanoscience & Nanotechnology

Dye labeling for optical imaging biases drug carriers' biodistribution and tumor uptake

Sarah Schraven, Stefanie Rosenhain, Ramona Brueck, Tim Marvin Wiechmann, Robert Pola, Tomas Etrych, Wiltrud Lederle, Twan Lammers, Felix Gremse, Fabian Kiessling

Summary: Biodistribution of nanocarriers with different dye tags was compared, showing that hydrophobic dyes were preferentially taken up by tumor cells. The uptake was actively mediated but not influenced by transporters. Additionally, labeling significantly impacted the tumor accumulation and biodistribution of nanocarriers, emphasizing the need for low-interference dyes and further exploration of dye tags for unbiased results.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2023)

Article Nanoscience & Nanotechnology

HPMA copolymer conjugated 5-aminolevulinic acid exhibits superior efficacy for photodynamic therapy with tumor-responsive and targeting properties

Rayhanul Islam, Kevin Kotalik, Vladimir Subr, Shanghui Gao, Jian-Rong Zhou, Kazumi Yokomizo, Tomas Etrych, Jun Fang

Summary: In this study, a nanoformulation of 5-aminolevulinic acid (5-ALA) was developed for targeted photodynamic therapy. The nanoformulation, called P-ALA, exhibited rapid release in acidic tumor environment, increased cytotoxicity under light irradiation, and higher tumor accumulation compared to 5-ALA. The results suggest the potential application of P-ALA as a nano-designed photosensitizer for anticancer photodynamic therapy.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2023)

Article Pharmacology & Pharmacy

Polymer-Antimicrobial Peptide Constructs with Tailored Drug-Release Behavior

Robert Pola, Matej Vicha, Jiri Trousil, Eliska Grosmanova, Michal Pechar, Anna Rumlerova, Martin Studenovsky, Emilie Kucerova, Pavel Ulbrich, Barbora Vokata, Tomas Etrych

Summary: Microbial resistance is a significant issue in modern medicine. Antimicrobial peptides have shown potential as a solution, but their limitations in stability, toxicity, and immunogenic response have hindered their clinical application. In this study, polymer-antibacterial peptide constructs were designed and synthesized. The constructs demonstrated antibacterial activity against both gram-positive and negative bacteria, with the peptide being released from the polymer carrier in response to a pH decrease.

PHARMACEUTICS (2023)

Article Health Care Sciences & Services

Singlet Oxygen In Vivo: It Is All about Intensity-Part 2

Steffen Hackbarth, Shanghui Gao, Vladimir Subr, Lisheng Lin, Jakob Pohl, Tomas Etrych, Jun Fang

Summary: Recently, we discovered induced anoxia as a limiting factor for photodynamic tumor therapy. The amount of generated singlet oxygen depends on photosensitizer accumulation, efficiency, and illumination intensity. Our experimental results provide proof for the described model and demonstrate characteristic changes in signal kinetics of singlet oxygen and photosensitizer phosphorescence in vivo, allowing for better optimization and coordination of PDT drugs and treatment.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Article Engineering, Biomedical

Adaptable polymerization platform for therapeutics with tunable biodegradability

M. Hrochova, L. Kotrchova, M. Frejkova, R. Konefal, S. Gao, J. Fang, L. Kostka, T. Etrych

Summary: Biodegradable polymer-based therapeutics have become essential drug delivery biomaterials. This study presents an adaptable polymerization platform for the synthesis of long-circulating, stimulus-sensitive and biodegradable biomaterials. The controlled polymerization allows for controlled degradation and increased antitumor efficacy.

ACTA BIOMATERIALIA (2023)

Article Materials Science, Multidisciplinary

Radiosensitizing molybdenum iodide nanoclusters conjugated with a biocompatible N-(2-hydroxypropyl)methacrylamide copolymer: a step towards radiodynamic therapy

Kaplan Kirakci, Robert Pola, Marina Rodrigues Tavares, Michal Pechar, Tomas Pribyl, Ivana Krizova, Jaroslav Zelenka, Tomas Ruml, Tomas Etrych, Kamil Lang

Summary: This study successfully conjugated octahedral molybdenum clusters with organic polymers, resulting in a highly stable nanosized conjugate. The conjugate demonstrated the ability to photosensitize the production of singlet oxygen without being toxic to cells. It also showed potential as a radiosensitizer upon X-ray irradiation. This research provides a promising therapeutic tool for photo/radiodynamic applications.

MATERIALS ADVANCES (2023)

No Data Available